Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 915-037-6 | CAS number: -
There is no data on acute oral, dermal or inhalation toxicity of silicocalcium. Therefore, weight of evidence approach is utilised in which the information on the toxicity of constituents and related compounds are used.
There were no data on acute non-human toxicity via oral route with silicocalcium. Therefore, weight of evidence approach is utilised. This means the use of information on the toxicity of composites (e.g. silicon and calcium) and related compounds - such as calcium silicate, which has similar order of water solubility releasing both silicon and calcium (OECD 2004).
Silicocalcium contains 55-63 wt-% of silicon and 28-32 wt-% of calcium. Other relevant constituents include iron and aluminium, which comprise up to 10 and up to 2.5 wt-% of the silicocalcium, respectively. The surface of silicocalcium is composed mainly of silicon and calcium rich oxides. Silicon is released from CaSi at similar or somewhat lower levels than from amorphous silicon dioxide (pyrogenic silica). The release of iron from silicocalcium is very restricted and resembles the release of iron from pyrogenic silica. Thus, amorphous silica is used for read-across in the assessment of the toxicity of CaSi. However, since significant levels of calcium are also released from CaSi matrix the impact of this element on the acute toxicity of CaSi should be also assessed.
Also small amounts of aluminium are released from silicocalcium matrix in synthetic biological fluids in vitro. In the assessment of the acute toxicity of silicocalcium, the possible impact of aluminium on the toxicity of silicocalcium should be taken into account.
Acute oral toxicity of amorphous silicon dioxide is >2000 mg/kg in rats. Also calcium silicate, which has the same order of water solubility than with CaSi and which release both silicon and calcium has shown low acute oral toxicity (LD50,rats >......)
Calcium (present in ferrosilicocalcium 28-32% w/w) is not acutely toxic as poorly soluble compound (oral LD50>2,000 mg/kg) and even the water soluble calcium chloride has LD50of 1,000 mg/kg.
Aluminium is a minor composing element of silicocalcium, The acute toxicity of metallic aluminium and aluminium compounds has been studied to be low, the reported oral LD50values being in the range of several hundred to 1,000 mg aluminium/kg body weight per day (EHC 1997). Furthermore, the LC50values for inhalation have not been identified for aluminium and its compounds (EHC 1997). Thus, silicocalcium unlikely has acute oral toxic properties.
Inhalation and dermal acute toxicity of silicon is low (do not exceed the classification limits).
Following inhalation exposure of rats to the highest technically feasible concentrations of 140 to ca. 2,000 mg/m3synthetic amorphous silica, no lethal effects were observed. The acute inhalation of synthetic amorphous silica dust may cause discomfort and stress as well as sign of local irritation to nasal, bronchiolar and ocular mucous membranes. Read across from the synthetic amorphous silica dusts suggests that calcium silicon is acutely non-toxic via inhalation.
Conclusion: Silicocalcium is not acutely toxic via oral, inhalation or dermal route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again